8 Years Exporter Albendazole Tablets - Amoxicillin+Cloxacillin for Oral Suspension – KeMing Medicines Detail:
| FOB Price | Inquiry |
| Min.Order Quantity | 20,000 bottles |
| Supply Ability | 1,000,000 bottles/Month |
| Port | Shanghai |
| Payment Terms | T/T in advance |
| Product Detail | |
| Product name | Amoxicillin+Cloxacillin for Oral Suspension |
| Specification | 100+25mg/5ml 100ml |
| Description | An orange granules |
| Standard | Factory Standard |
| Package | 1bottle/box |
| Transportation | Ocean,Land,Air |
| Certificate | GMP |
| Price | Inquiry |
| Quality guaranteeperiod | for 36 months |
| Product Description | [Pharmacokinetics]： Amoxicillin is bactericidal against non β-lactamase producing gm+ve organisms and selected gm-ve pathogens. Cloxacillin is a β-lactamase resistant penicillin active against gm+ve organisms including β-lactamase (penicillinase) producing strains of Staphylococci. It is highly active against Staph aureus, Strep pyogenes, Strep viridans and Strep pneumoniae. Also effective against penicillinase producing gonococci and against N meningitidis and H influenzae. 500~1000 mg(20~40ml) Three times / day. |
Product detail pictures:
Related Product Guide:
Prescription Drugs Can Lead to Vitamin and Mineral Deficiencies
Drugs, Vitamins, Pills, Pills, Pills
We've been commitment to offer the competitive rate ,outstanding merchandise good quality, too as fast delivery for 8 Years Exporter Albendazole Tablets - Amoxicillin+Cloxacillin for Oral Suspension – KeMing Medicines, The product will supply to all over the world, such as: Swansea, Manchester, Miami, We will not only continuously introduce technical guidance of experts from both home and abroad, but also develop the new and advanced products constantly to satisfactorily meet the needs of our clients all over the world.
By Melissa from Norway - 2018.09.23 17:37
This company has a lot of ready-made options to choose and also could custom new program according to our demand, which is very nice to meet our needs.
By Genevieve from Greek - 2018.10.01 14:14
